Management of Contagious Molluscum (Molluscum Contagiosum)

First‑Line Therapies for Symptomatic or Cosmetically Bothersome Lesions

The American Academy of Pediatrics recommends 10 % potassium hydroxide (KOH) or liquid‑nitrogen cryotherapy as equivalent first‑line options in children; both achieve high clearance rates, while cryotherapy carries a higher risk of post‑inflammatory hyperpigmentation or scarring. [1][2] – Evidence level: moderate‑quality comparative studies.

Potassium hydroxide 10 % is especially useful for lesions located in cosmetically sensitive areas (e.g., face, neck). 1 – Evidence level: moderate‑quality comparative studies.

Cryotherapy is highly effective but may cause post‑inflammatory hyperpigmentation or, less commonly, scarring; the risk is accentuated in patients with darker skin tones. [1][2]4 – Evidence level: moderate‑quality comparative studies.

Observation (Expectant Management) for Asymptomatic or Minimally Symptomatic Disease

Spontaneous resolution typically occurs within 6–12 months, although clearance can take up to 4 years. [1][2]3 – Evidence level: observational cohort data.

Watchful waiting is appropriate for immunocompetent individuals with uncomplicated lesions. 1 – Evidence level: expert consensus/observational data.

Ocular Involvement (Lesions on Eyelids with Associated Conjunctivitis)

Definitive management requires removal of eyelid lesions by incision and curettage, simple excision, excision with cautery, or cryotherapy. [5][6] – Evidence level: Level B (prospective case series).

Conjunctivitis may persist for several weeks after lesion removal before fully resolving. [5][6] – Evidence level: Level B (prospective case series).

In patients with multiple ocular lesions, early identification and treatment of incipient lesions reduces the risk of recurrence. [5][6] – Evidence level: Level B (prospective case series).

Treatments Not Recommended

Imiquimod showed no benefit compared with placebo in randomized controlled trials. [1][2]4 – Evidence level: Level A (RCTs).

Cantaridine (cantaridina) failed to demonstrate a statistically significant advantage over placebo in a small RCT (n = 29). [1][2]4 – Evidence level: Level A (small RCT).

Special Populations

Patients with Eczema or Underlying Dermatoses

Active treatment with potassium hydroxide 10 % or cryotherapy provides superior outcomes in this group. [1][2] – Evidence level: moderate‑quality comparative studies.

Immunocompromised Individuals

The presence of multiple large lesions with minimal conjunctival inflammation may signal underlying immunosuppression. [5][6] – Evidence level: Level B (clinical observation).

Athletes and Transmission Prevention

Cover lesions, avoid sharing towels or other fomites, and limit exposure to pools known to be associated with outbreaks. 1 – Evidence level: expert consensus.

Follow‑Up and Referral

Routine follow‑up is unnecessary unless conjunctivitis persists after ocular lesion removal. [5][6] – Evidence level: Level B (clinical observation).

Refer to dermatology for patients with numerous or refractory lesions. [5][6] – Evidence level: expert consensus.